The NY Times reports that a federal judge on Monday struck down patents on two genes linked to breast and ovarian cancer. The decision, if upheld, could throw into doubt the patents covering thousands of human genes and reshape the law of intellectual property.
Post Tagged with: "myriad genetics"
Recent Posts
Why the Verdict on Social Media Defective Design Harming Children Gets the Instinct Right But the Law Wrong 
Scoping in the Tech Giants: Bill C-22’s International Production Order and the Shift to a Less Privacy-Protective Cross-Border Disclosure System 
The Law Bytes Podcast, Episode 263: The Lawful Access Act Roundtable With David Fraser and Robert Diab 
When Writing About Antisemitism Proves the Point: What the Replies Reveal 
Acting on Antisemitism: If This Was Always Possible, Why Didn’t It Happen Sooner?
